Lost in Science Chris Lassig, Stuart Burns and Claire Farrugia and others.

This week on Lost in Science, Claire explores revolutionary research that uses a gut bacteria enzyme to convert blood types, aiming to make all blood donations universally compatible. And Catriona discusses the latest in organ transplants, including a successful pig kidney transplant into a human facilitated by groundbreaking CRISPR gene editing. Tune in to learn how these innovative scientific breakthroughs could dramatically change the landscape of medicine.

This week, Chris talks to rehabilitation specialist Professor Steven Faux about his new book on Long Covid, to find out what we know about it and its causes, and current best practice for treatment and recovery. We also speak to comedian Alanta Colley about the Sci Fight comedy debates, with the next event on 2 May 2024 discussing Elon Musk’s Neuralink brain implants.Long Covid by Professor Steven Faux, https://www.murdochbooks.com/search?page=1&keyword=long%20covidSci Fight Science Comedy Debates, https://www.scifight.com.au/

This week on Lost in Science, Stu examines the invasive fire ant crisis and innovative control measures. Meanwhile, Chris explores bird evolution, spotlighting the Hoatzin, or "stink bird," known for its unique digestion and ancient traits. Tune in to discover how science is tackling ecological threats and unraveling avian mysteries. 

Even though we’re staying out of the Sun this week, we can’t stop thinking about it! Cat tells us all about the Sun’s corona, its crown-like atmosphere, and the solar wind of particles streaming out from it; and Claire runs us through the science and history of solar eclipses.

Chris looks into the energy costs and economics of AI and how wider use will affect them, while Stu looks into the science of some of the claims around the supposed forest communication networks some authors have described. 

This week on the show Catriona takes us into the realm of tuberculosis vaccines, describing the latest breakthroughs and how they diverge from conventional approaches. From novel formulations to enhanced efficacy, explore the promising advancements reshaping the fight against TB. Meanwhile, Stu delves into COVID-19 research, analyzing global data to uncover insights into mortality rates and the effectiveness of containment measures, including the astonishing tale of a German citizen receiving over 200 vaccine doses.